(Q53483873)

14 May 2018

title

Hexadecylphosphocholine differs from conventional cytostatic agents. (English)

1 reference

14 May 2018

1 reference

M R Berger

1

1 reference

14 May 2018

B Betsch

2

1 reference

14 May 2018

M Gebelein

3

1 reference

14 May 2018

E Amtmann

4

1 reference

14 May 2018

P Heyl

5

1 reference

14 May 2018

H R Scherf

6

1 reference

14 May 2018

publication date

1 January 1993

1 reference

14 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

14 May 2018

volume

119

1 reference

14 May 2018

issue

9

1 reference

14 May 2018

page(s)

541-548

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01686464

exact match

0 references

cites work

Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase C-type reactions

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01686464

Stromal influences on breast cancer cell growth

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01686464

Induction of tumor cell differentiation by alkylphosphocholines: a new approach for in vitro screening

21 January 2018

1 reference

12 December 2020

Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients

1 reference

12 December 2020

Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells

1 reference

12 December 2020

Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas

1 reference

12 December 2020

Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations

1 reference

12 December 2020

Alkyl phosphocholines: toxicity and anticancer properties

1 reference

12 December 2020

Significance of freshly cultured fibroblasts from different tissues in promoting cancer cell growth

1 reference

12 December 2020

Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo

1 reference

12 December 2020

Different effects of cyclophosphamide in vivo and phosphamide mustard in vitro on two cell clones of chemically induced mammary carcinoma of the rat

1 reference

12 December 2020

Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)

1 reference

12 December 2020

DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties

1 reference

12 December 2020

Synthesis of hexadecylphosphocholine (miltefosine)

1 reference

12 December 2020

The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation

1 reference

12 December 2020

New cytostatics with experimentally different toxic profiles

1 reference

12 December 2020

Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats

1 reference

12 December 2020

Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity

1 reference

12 December 2020

Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells

1 reference

12 December 2020

In vitro investigations on the antineoplastic effect of hexadecylphosphocholine

1 reference

12 December 2020

Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity

1 reference

12 December 2020

New cytostatics--more activity and less toxicity

1 reference

12 December 2020

Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts

1 reference

12 December 2020

Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2

1 reference

12 December 2020

Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01686464

1 reference

14 May 2018

PubMed ID

8392075

1 reference

14 May 2018